Micrologix biotech Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micrologix biotech

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sean Janzen who wrote (727)	7/15/2000 9:33:07 AM
From: Larry G.	of 792

Sean, You have mentioned that MBI 226 is going to be used in severe acne. I do not know why I was doubtful but you are very right. I had an idea. I believe that infection is a very big problem for people with 3rd degree burns. MBI 226 could be used in new indication, treatment of burn victims. MBI 226 has passed phase 1 and 2 so they may be able to start phase 3 with little preparation. I think they are watching their money so I do not know when they would start but after they have some positive results with CVCs. I do not know how large the target market would be but I would think it would be significant. Do you or anyone else know market size of this indication? It would be very helpful for burn victims. If we look at all the indications, I think MBI 226 may have a larger target market than ever dreamed of. MBI is going to make a lot of people rich and in a very short time. We could be at $100 in one year but I would think a minimum of $40. Can you or anyone else, think of any other indications MBI 226 could be used for?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next